383 related articles for article (PubMed ID: 19887275)
1. [Sugammadex: a new approach to muscle relaxation and its reversal].
Duvaldestin P
Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S39-40. PubMed ID: 19887275
[No Abstract] [Full Text] [Related]
2. [Indications and clinical use of sugammadex].
Debaene B; Meistelman C
Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S57-63. PubMed ID: 19887279
[TBL] [Abstract][Full Text] [Related]
3. [Sugammadex: something new to improve patient safety or simply a gadget?].
Plaud B
Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S64-9. PubMed ID: 19887280
[TBL] [Abstract][Full Text] [Related]
4. [Sugammadex, a novel drug for neuromuscular blockade reversal].
Fernández Meré LA; Alvarez-Blanco M
Rev Esp Anestesiol Reanim; 2010 Feb; 57(2):95-102. PubMed ID: 20337001
[TBL] [Abstract][Full Text] [Related]
5. A novel approach to reversal of neuromuscular blockade.
Della Rocca G; Pompei L
Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157
[TBL] [Abstract][Full Text] [Related]
6. Reversal of neuromuscular block with a selective relaxant-binding agent: sugammadex.
Ren WH; Jahr JS
Am J Ther; 2009; 16(4):295-9. PubMed ID: 19535969
[TBL] [Abstract][Full Text] [Related]
7. Sugammadex in anesthesia practice.
Duvaldestin P; Plaud B
Expert Opin Pharmacother; 2010 Nov; 11(16):2759-71. PubMed ID: 20977408
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacology of sugammadex].
Meistelman C; Fuchs-Buder T
Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S51-6. PubMed ID: 19887278
[TBL] [Abstract][Full Text] [Related]
9. Sugammadex: the first selective binding reversal agent for neuromuscular block.
Kovac AL
J Clin Anesth; 2009 Sep; 21(6):444-53. PubMed ID: 19833281
[TBL] [Abstract][Full Text] [Related]
10. Neuromuscular transmission: new concepts and agents.
de Boer HD
J Crit Care; 2009 Mar; 24(1):36-42. PubMed ID: 19272537
[TBL] [Abstract][Full Text] [Related]
11. A new approach to anesthesia management in myasthenia gravis: reversal of neuromuscular blockade by sugammadex.
de Boer HD; van Egmond J; Driessen JJ; Booij LH
Rev Esp Anestesiol Reanim; 2010 Mar; 57(3):181-4. PubMed ID: 20422852
[TBL] [Abstract][Full Text] [Related]
12. Preclinical pharmacology of sugammadex.
Bom A; Hope F; Rutherford S; Thomson K
J Crit Care; 2009 Mar; 24(1):29-35. PubMed ID: 19272536
[TBL] [Abstract][Full Text] [Related]
13. Reversal of profound rocuronium or vecuronium-induced neuromuscular block with sugammadex in isoflurane-anaesthetised dogs.
Mosing M; Auer U; West E; Jones RS; Hunter JM
Vet J; 2012 Jun; 192(3):467-71. PubMed ID: 22030475
[TBL] [Abstract][Full Text] [Related]
14. An update on sugammadex sodium.
Welliver M; Cheek D
AANA J; 2009 Jun; 77(3):219-28. PubMed ID: 19645172
[TBL] [Abstract][Full Text] [Related]
15. [Sugammadex, a revolutionary new drug to reverse neuromuscular block].
Alvarez Gómez JA
Rev Esp Anestesiol Reanim; 2007 Apr; 54(4):205-7. PubMed ID: 17518169
[No Abstract] [Full Text] [Related]
16. A temporary decrease in twitch response during reversal of rocuronium-induced muscle relaxation with a small dose of sugammadex.
Eleveld DJ; Kuizenga K; Proost JH; Wierda JM
Anesth Analg; 2007 Mar; 104(3):582-4. PubMed ID: 17312212
[TBL] [Abstract][Full Text] [Related]
17. The concept behind sugammadex.
Epemolu O; Bom A
Rev Esp Anestesiol Reanim; 2014 May; 61(5):272-6. PubMed ID: 24636599
[TBL] [Abstract][Full Text] [Related]
18. Reversal of prolonged rocuronium neuromuscular blockade with sugammadex in an obstetric patient with transverse myelitis.
Weekes G; Hayes N; Bowen M
Int J Obstet Anesth; 2010 Jul; 19(3):333-6. PubMed ID: 20627694
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of new neuromuscular concepts and agents: so long, neostigmine! So long, sux!
Lee C; Katz RL
J Crit Care; 2009 Mar; 24(1):43-9. PubMed ID: 19272538
[TBL] [Abstract][Full Text] [Related]
20. Sugammadex: a selective relaxant-binding agent providing rapid reversal.
Rex C; Bergner UA; Pühringer FK
Curr Opin Anaesthesiol; 2010 Aug; 23(4):461-5. PubMed ID: 20489603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]